Pharma firm to pay $1.3B fine for vaccine scandal

China |  News | 0 Comment | 17 Oct, 2018

Changchun Changsheng Life Sciences Ltd has been charged with a huge fine of $1.3 billion for falsifying production records in a scandal that prompted a nationwide crackdown on the vaccine i...Read more

JHL Biotech receives China approval for cancer Biosimilar

China |  News | 0 Comment | 16 Oct, 2018

JHL Biotech announced that the National Medical Products Administration of the PRC (NMPA) has approved JHL's Phase I and Phase III Clinical Trial Application for a proposed bevacizumab bios...Read more

Curetis, Beijing Clear Biotech expand strategic collaboration

China |  News | 0 Comment | 16 Oct, 2018

Curetis, a developer of next-level molecular diagnostic solutions, has announced that it has significantly expanded its strategic collaboration with Beijing Clear Biotech (BCB) for the excl...Read more

MEI Pharma, BeiGene to co-develop cancer drug

China |  News | 0 Comment | 12 Oct, 2018

MEI Pharma, a late-stage pharmaceutical company focused on advancing new therapies for cancer and BeiGene, a commercial-stage biopharmaceutical company focused on developing and commer...Read more

Rgenix raises $40 M in series C funding

China |  News | 0 Comment | 12 Oct, 2018

Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced that it has raised $40 million in a Series C fi...Read more

UniCAR teams up with Terumo BCT to improve CAR T-cell therapies

China |  News | 0 Comment | 11 Oct, 2018

Shanghai UniCAR-Therapy Bio-Medicine Technology Co. chose Terumo BCT and its cell expansion devices to automate its cell therapy manufacturing process for chimeric antigen receptor (CAR) T-...Read more

Jinxin Fertility announces completion of major financing round

China |  News | 0 Comment | 10 Oct, 2018

With a potential market size of more than RMB100 billion, assisted reproduction has become one of the fastest growing markets among the healthcare industry in China. The promising prospect ...Read more

PolyU team develops new system for elderly care

China |  News | 0 Comment | 10 Oct, 2018

The Hong Kong Polytechnic University (PolyU) has developed eNightLog, a multi-function nighttime monitoring system for elderly with dementia, to track their respiration and activities in be...Read more

Yisheng receives approval for rabies vaccine clinical study

China |  News | 0 Comment | 10 Oct, 2018

Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immune modulator biotherapeutics and vaccines, has announce...Read more

AI based healthcare startup raises $15M funding

China |  News | 0 Comment | 09 Oct, 2018

Deep Intelligent Pharma, a healthcare AI start-up providing new drug research and development services for pharmaceutical companies, has recently raised a $15 million series B round of fina...Read more

CASI Pharmaceuticals appoints new president for China Operations

China |  News | 0 Comment | 08 Oct, 2018

CASI Pharmaceuticals, a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients i...Read more

Cellular Bio gets NCI patent license for solid tumour immunotherapy

China |  News | 0 Comment | 05 Oct, 2018

Cellular Biomedicine Group Inc. (CBMG), a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, h...Read more

AXA Hong Kong, HKSH medical group enter into collaboration

China |  News | 0 Comment | 04 Oct, 2018

AXA Hong Kong and HKSH Medical Group has entered into collaboration under which HKSH will be the first and biggest partner of the market-first "AXA Signature Network." Doctors from HKSH wil...Read more

Hong Kong Department of Health approves Biktarvy

China |  News | 0 Comment | 03 Oct, 2018

Singapore - Gilead Sciences announced that the Hong Kong Department of Health has approved Biktarvy (bictegravir 50mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg; BIC/FTC/TAF), a once-...Read more

PAGD enters into an agreement with Grab

China |  News | 0 Comment | 03 Oct, 2018

China's leading one-stop healthcare ecosystem platform, Ping An Good Doctor (PAGD) has announced that it has entered into a subscription agreement with Grab for a joint venture in Southeast...Read more

CANbridge Pharma submits NDA for NERLYNX in China

China |  News | 0 Comment | 02 Oct, 2018

CANbridge Pharmaceutical Inc., a biopharmaceutical company developing Western drug candidates in China and North Asia, announced that it has filed a New Drug Application (NDA) to China&rsqu...Read more

CSPC Pharma, Verastem sign license agreement for cancer treatment

China |  News | 0 Comment | 01 Oct, 2018

Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, and CSPC Pharmaceutical Group Limited, a leading pharmace...Read more

Novartis collaborates with Cellular Biomedicine for CAR-T Therapy

China |  News | 0 Comment | 28 Sep, 2018

Cellular Biomedicine Group Inc. (CBMG) has entered into a strategic licensing and collaboration agreement with Novartis to manufacture and supply the CAR-T cell therapy Kymriah (tisagenlecl...Read more